Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Frontiers in Oncology
|
June 17, 2017
Delineation of the Prostate Bed: The "Invisible Target" Is Still an Issue?
Igor Latorzeff, Paul Sargos, Geneviève Loos, et al.
Cureus
|
December 15, 2017
Intraprostatic Fiducials Compared with Bony Anatomy and Skin Marks for Image-Guided Radiation Therapy of Prostate Cancer
Juliette Moreau, Julian Biau, Jean-Louis Achard, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
August 21, 2025
Role of radiotherapy in the management of bladder cancer: Recommendations of the French Society for Radiation Oncology, 2025 update
Paul Sargos, Louis-Marie Sauvage, Jonathan Khalifa, et al.
Practical Radiation Oncology
|
September 6, 2025
Urinary organs-at-risk for radiotherapy following radical prostatectomy: contouring guidelines on behalf of the Francophone Group of Urological Radiation Therapy (GFRU)
Jennifer Le Guevelou, Thomas Zilli, Arthur Peyrottes, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
November 8, 2025
Radiotherapy for penile cancers: 2025 update
Geneviève Loos, Alexandre Escande, Sabrina Aziez, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 18, 2018
Early Toxicity of a Phase 2 Trial of Combined Salvage Radiation Therapy and Hormone Therapy in Oligometastatic Pelvic Node Relapses of Prostate Cancer (OLIGOPELVIS GETUG P07)
Loig Vaugier, Clément Palpacuer, Emmanuel Rio, et al.
European Urology Oncology
|
February 8, 2023
The Safety and Efficacy of Salvage Stereotactic Radiation Therapy in Patients with Intraprostatic Tumor Recurrence After Previous External Radiation Therapy: Phase 1 Results from the GETUG-AFU 31 Study
David Pasquier, Thomas Lacornerie, Stéphane Supiot, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
May 15, 2026
OLIGOPELVIS 2-GETUG P12- elective nodal radiotherapy for oligorecurrent pelvic/para-aortic nodes in prostate cancer: early toxicity of a randomized phase 3 trial
Hugo Corda, Audrey Blanc-Lapierre, Grégoire Pigne, et al.
European Urology Oncology
|
June 11, 2026
Study Protocol of OLIGOPELVIS 2-GETUG P12: A Randomized Phase 3 Study Comparing Intermittent Androgen-deprivation Therapy with or Without Salvage High-dose Intensity-modulated Radiotherapy to Oligorecurrent Pelvic and Para-aortic Lymph Nodes in Patients with Biochemically Relapsing Prostate Cancer
Quentin Josset, Audrey Blanc-Lapierre, Grégoire Pigne, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 21, 2026
Pushing the boundaries of SBRT in irradiated territories for nodal oligorecurrent prostate cancer: outcomes of the CYGNUS multicentric retrospective study
Ewen Anger, Stephane Supiot, Quentin Josset, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Frontiers in Oncology
|
June 17, 2017
Delineation of the Prostate Bed: The "Invisible Target" Is Still an Issue?
Igor Latorzeff, Paul Sargos, Geneviève Loos, et al.
Cureus
|
December 15, 2017
Intraprostatic Fiducials Compared with Bony Anatomy and Skin Marks for Image-Guided Radiation Therapy of Prostate Cancer
Juliette Moreau, Julian Biau, Jean-Louis Achard, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
August 21, 2025
Role of radiotherapy in the management of bladder cancer: Recommendations of the French Society for Radiation Oncology, 2025 update
Paul Sargos, Louis-Marie Sauvage, Jonathan Khalifa, et al.
Practical Radiation Oncology
|
September 6, 2025
Urinary organs-at-risk for radiotherapy following radical prostatectomy: contouring guidelines on behalf of the Francophone Group of Urological Radiation Therapy (GFRU)
Jennifer Le Guevelou, Thomas Zilli, Arthur Peyrottes, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
November 8, 2025
Radiotherapy for penile cancers: 2025 update
Geneviève Loos, Alexandre Escande, Sabrina Aziez, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 18, 2018
Early Toxicity of a Phase 2 Trial of Combined Salvage Radiation Therapy and Hormone Therapy in Oligometastatic Pelvic Node Relapses of Prostate Cancer (OLIGOPELVIS GETUG P07)
Loig Vaugier, Clément Palpacuer, Emmanuel Rio, et al.
European Urology Oncology
|
February 8, 2023
The Safety and Efficacy of Salvage Stereotactic Radiation Therapy in Patients with Intraprostatic Tumor Recurrence After Previous External Radiation Therapy: Phase 1 Results from the GETUG-AFU 31 Study
David Pasquier, Thomas Lacornerie, Stéphane Supiot, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
May 15, 2026
OLIGOPELVIS 2-GETUG P12- elective nodal radiotherapy for oligorecurrent pelvic/para-aortic nodes in prostate cancer: early toxicity of a randomized phase 3 trial
Hugo Corda, Audrey Blanc-Lapierre, Grégoire Pigne, et al.
European Urology Oncology
|
June 11, 2026
Study Protocol of OLIGOPELVIS 2-GETUG P12: A Randomized Phase 3 Study Comparing Intermittent Androgen-deprivation Therapy with or Without Salvage High-dose Intensity-modulated Radiotherapy to Oligorecurrent Pelvic and Para-aortic Lymph Nodes in Patients with Biochemically Relapsing Prostate Cancer
Quentin Josset, Audrey Blanc-Lapierre, Grégoire Pigne, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 21, 2026
Pushing the boundaries of SBRT in irradiated territories for nodal oligorecurrent prostate cancer: outcomes of the CYGNUS multicentric retrospective study
Ewen Anger, Stephane Supiot, Quentin Josset, et al.
Page
of 1